📄 Extracted Text (1,278 words)
10/26/2010 9:18:41 AM FROM: LABCORP LCLS BLK TO: 12125351172 LABCORP Page 3 of 4
LabCorp Raritan
LabgPip 69 First Avenue
Raritan NJ 08869-1800
PattraiNuite
Phone: 800-631-5250
speommmmew
EPSTEIN, JESTREY 294-142-3828-0
Maria Swab,. PatNita ID Coatrol 1•11Tilbet DM< tad Time Collected Date Repotted Sea AsianAM/ Date of Sal
31143092 AE/01143392 10/21/10 09:00 10/26/10 M 59/09/01 01/20/51
TESTS RESULT FLAG UNITS RICTERENCE INTERVAL IAS
Protein Negative Negative/Trace 01
Glucose Negative Negative 01
Ketones Negative Negative 01
Occult Blood Negative Negative 01
Bilirubin Negative Negative 01
Urobilinogen,Semi-On 0.2 EU/dL 0.0 - 1.9 01
Nitrite, Urine Negative Negative 01
Microscopic Examination
Microscopic follows if indicated. 01
Lipid Panel With LDL/HDL Ratio
Cholesterol, Total 226 Nigh mg/dL 100 - 199 01
Triglycerides 996 Sigh mg/dL 0- 149 01
RDL Cholesterol 31 Low mg/dL >39 01
Comment 01
According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 79 High mg/dL 5 - 40
LDL Cholesterol Cale 116 High mg/dL 0 - 99
LDL/HDL Ratio 3.7 High ratio units 0.0 - 3.6
C-Reactive Protein, Cardiac 0.79 mg/L 0.00 - 3.00 01
Relative Risk for Future Cardiovascular Event
Low <1.00
Average 1.00 - 3.00
High >3.00
Glyaohemoglobio (01b),Total
Glycohemoglobin (GHb), Total 6.4 <9.0 i 01
Diabetic Adult
<9.0
Healthy Adult
3.9 - 7.3
(DCCT/NGSP)
Current ADA guidelines recommend a treatment goal of
<7.0% HgbAlc for diabetic patients, which corresponds
to a <9.0% Glycohemoglobin result with this method.
Prostate—Specific Ag, Serum
Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
EPSTEIN, JEFFREY 294-142-382B-0 Seq 12713
10/26/10 10:17 ET DUPLICATE FINAL REPORT Page 2 of 3
Ths d0CIAINIX COO Win pave Le and confideanal health infoonatIon pothered by salt and federal O20Ot1 10 Labotateey Cot potation d manta e Moldangs
If you have received this document mtITOT. plea se call 000-745-0233 All Rights Reserved
DOC1 Vet. 1..13
EFTA00727561
LO/26/2010 9:18:41 AM FROM: LABCORP LCLS 8LK TO: 12125351172 LABCORP Page 4 of 4
LabCorp Raritan
LabCcarp RmeniNnu
69 First Avenue
Raritan NJ 08869-1800 Phone: 800-631-5250
SpeommNumber
EPSTEIN, JEFFREY 294-142-3828-0
Aco Numbed Itieml115 CommINumbet I DveasTimeColleced I DueReponed Su l AgeffAVD) DareaBirth
31143092 I AEA31143092 10/21/10 09:00 10/26/10 M 59/09/01 01/20/51
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
Vitamin D, 25—Hydroxy 26.9 Low ng/mL 32.0 100.0 01
Recent studies consider the lower limit of 32.0 ng/mL to be a
threshold for optimal health.
Hollis BW. J Nutr. 2005 Feb;135(2):317-22.
Homosyst(e)ine, Plasma 12.9 umol/L 0.0 - 15.0 01
TSH 2.040 uIU/ral, 0.450 - 4.500 01
Lp-PLA2 82 Low ng/mL 131 - 199 02
Low Risk <200
Moderate Risk 200 - 235
High Risk >235
Uric Acid, Serum 7.1 mg/dL 2.4 - 8.2 01
greatine Rinams,Total,Rerum 162 U/L 24 - 204 01
01 RN LabCorp Raritan Dir: Michael Mahoney, MD
69 First Avenue, Raritan. NJ 08869-1800
02 BN LabCorp Burlington Dir: William F Hancock, MD
1447 York Court, Burlington, NC 27215-3361
For inquiries, the physician may contact Branch: 800-745-0233 Lab: 800-631-5250
EPSTEIN, JEFFREY 294-142-3828-0 Sol I VD
10/26/10 10:17 ET DUPLICATE FINAL REPORT Page 3 of 3
nes documenrccatabs private an0 confidential health Information protected by sure and federal law. O2004--10 Labial coy Corporation of America a Holdings
If you bete received this document in error, please cal) 800-745-0233 AU Rights Reserved
DCCI Vet: 1.43
EFTA00727562
S 10/26/2010 9:18:40 AM FROM: LABCORP LCLS BLK TO: 12125351172 LABCORP Page 1 of 4
I
• s TO: KIMBERLY Woodson Merrell
I
LabCorp Raritan
69 First Avenue
Raritan N 08869-1800 Phone.800-762 -4344
SpsismaNimber PussiM CattedNmbor AamorNmiber AossaMmuNtrather Route
294-142-3820-0 60126177866 31143092 212-535-1012 10
NpoLamNam mwmankiens
EPSTEIN Woodson Merrell
Puna Pest Nast Peace Mittlae Name
JETTAZY
Domani Ft•ealheta Told Volume 44 E 67th St
212-772-9461 New York NY 10065
Age (YAM Date of Binh Sex Faint
59/09/01 01/20/51 N Yes
hen Address Addax./ information
6110 RED HOOK QUARTERS RC: ,HS: ,TP: ,PP: ,CT:
SAINT THOMAS VI 00802
UPIN: A62553
DessedThaCollacid DueBotem Due aed The Rmoned Obrialw/han RN Mye0wID
10/21/10 09:00 10/22/10 10/26/10 09:14ET MERRELL , W 1023/53509 MERRELL
TestrOrdeeed
Arsenic, Blood; Mercury, Blood
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
Arsenic, Blood 7 ug/L 2 - 23 01
Detection Limit - 1
Mercury, Blood 2.7 ug/L 0.0 - 14.9 01
Environmental Exposure: <15.0
Occupational Exposure:
BEI - Inorganic Mercury: 15.0
Detection Limit 1.0
01 BN LabCorp Burlington Dir: William F Hancock, MD
1447 York Court, Burlington, NC 27215-3361
For inquiries, the physician may contact Branch: 800-746-0233 Lab: 800-762-4344
EPSTEIN, JEFFREY 294-142-3820-0 scorn
10/26/10 10:17 ET DUPLICATE FINAL REPORT Page 1 of 1
The document MUSS IMVISt and confidenbal health Informatiat prolixled by state and federal law. 02004-10 Laboratory Capaation of AMISS • Holdings
U you have xeceived this document 111 error, please an 800-745-0233 AU Rights Reserved
DOCI Va: 143
EFTA00727563
1.0/26/2010 9:18:40 AM FROM: LABCORP LCLS BLK TO: 12125351172 LABCORP Page 2 of 4
LabCorp Raritan
Lots.Cfarp
SpainsoNsselm IssmotS,
69 First Avenue
Raritan, N 08869-1800
CamgMmbet AcmoaNwthot
Phone:800-631-5250
AcoomPkaeNabot Room
294-142-3828-0 AEA31143092 31143092 212-536-1012 70
Nom Um Nine Accooa Address
EPSTEIN Woodson Merrell
NoraPimMuse ftleaMakRerot
JEFFREY
Power SN Aden Roos Toed Vsne 44 E 67th St
212-772-9461 New York NY 10065
NaNAMW lameolBleo Sea Fan
59/09/01 01/20/51 M Yes
posommem mmikaumwaamw
6100 RED HOOK QUARTERS
SAINT THOMAS VI 00802
UPIN: A62553
Due sod Tem Cada& Cep Sewed Dee sod Time Repined Pftsiolso Nine KM Mosioso ID
10/21/10 09:00 10/22/10 10/26/10 09: 14ET MERRELL . W 1023153509 MERRELL
Taw Wend
Comp. Metabolic Panel (14); Urinalysis, Routine; Lipid Panel With LDL/MDL Ratio; C-Reactive
Protein, Cardiac; Glycohemoglobin (OW ,Total; Prostate-Specif .c Ag, Serum; Vitamin D,
25-Hydroxy; Homocyst(e)ine, Plasma; 1551 Lp-PLA2; Uric Acid, Serum; Gneiss.). Plasma; Creatine
Ki nose.Tot ol,Sorum
TESTS RESULT FLAG UNITS REFERENCE INTERVAL MB
Corp. Metabolic Panel (14)
Glucose, Plasma 88 mg/dL 65 - 99 01
BUN 18 mg/dL 5 - 26 01
Creatinine, Serum 1.11 mg/dL 0.76 - 1.27 01
eGFR >59 mL/min/1.73 >59
eGFR AfricanAmerican >59 mL/min/1.73 >59
Note: Persistent reduction for 3 months or more in an eGFR
<60 mL/min/1.73 m2 defines CKD. Patients with eGFR values
>1-60 mL/min/1.73 m2 may also have CKD if evidence of persistent
proteinuria is present. Additional information may be found at
www.kdogi.org.
BUN/Creatinine Ratio 16 8 - 27
Sodium, Serum 139 mmol/L 135 - 145 01
Potassium, Serum 4.1 mmol/L 3.5 - 5.2 01
Chloride, Serum 99 mmol/L 97 - 108 01
Carbon Dioxide, Total 25 mmol/L 20 - 32 01
Calcium, Serum 9.8 8.7 - 10.2 01
Protein, Total, Serum 7.6 g/dL 6.0 - 8.5 01
Albumin, Serum 4.4 mc:Iidll
: 3.5 - 5.5 01
Globulin, Total 3.2 g/dL 1.5 - 4.5
A/G Ratio 1.4 1.1 - 2.5
Bilirubin, Total 0.9 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 60 IU/L 25 150 01
AST (SGOT) 22 IU/L 0 40 01
ALT (SGPT) 24 IU/L 0 - 55 01
Urinalysis, Routine
Urinalysis Gross Exam 01
Specific Gravity 1.017 1.005 - 1.030 01
pH 6.0 5.0 - 7.5 01
Urine-Color Yellow Yellow 01
Appearance Clear Clear 01
NBC Esterase Negative Negative 01
EPSTEIN, JEFFREY 294-142-3828-0 Seq /inn
10/26/10 10:17 ET DUPLICATE FINAL REPORT Page 1 of 3
Ilas document cooralas private and confidential health Information protected by state and federal law. 02004- 10 Laboratory Corporation of America(2,Holding
If reline received this document in C11Of. please call S00-745-0233 AU Righu Reserved
DOC1 Vet: 1.41
EFTA00727564
ℹ️ Document Details
SHA-256
755d03e16813bd06711a503800929baccd1b47249ddbcd0b661b94e77f78e994
Bates Number
EFTA00727561
Dataset
DataSet-9
Document Type
document
Pages
4
Comments 0